AJ

Anju Jaiswal

Active Director Director DIN 09631965
DIN 09631965 First appointment Jul 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Anju Jaiswal

Data last updated:

Anju Jaiswal is a Director at Macarty Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Macarty Pharmaceuticals Private Limited reported revenue of ₹2.5 Lakh (FY 2024).

DIN 09631965
Primary Designation Director
Industry Chemicals
First Appointment 04 Jul 2022
Oldest Company Age 8 yrs
Largest company Macarty Pharmaceuticals Private Limited · ₹2.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jul 20222018₹2.5 Lakh (FY 2024)Active

Board colleagues of Anju Jaiswal

NameDINCompanyDesignation
Dolly Jaisawal08991511Macarty Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Macarty Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anju Jaiswal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anju Jaiswal

Anju Jaiswal currently holds 1 directorship: Macarty Pharmaceuticals Private Limited (Director, since 04 Jul 2022, revenue ₹2.5 Lakh (FY 2024)).

Anju Jaiswal was first appointed on 04 Jul 2022 as Director at Macarty Pharmaceuticals Private Limited.

The current boards of Anju Jaiswal's companies include Dolly Jaisawal (Macarty Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available